Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Sep;34(9):970–971. doi: 10.1136/jcp.34.9.970

Serum immunoreactive trypsin in beta-thalassaemia major.

M Hussain, P Dandona, S S Fedail, L Ramdial, D Flynn, A V Hoffbrand
PMCID: PMC494207  PMID: 7276222

Abstract

To assess the exocrine pancreatic function in beta-thalassemia major with iron overload, serum immunoreactive trypsin (IRT) was measured in 38 patients with this condition. In 23 (60%) patients' IRT was abnormal: it was subnormal in 16 patients and supranormal in seven. Whereas subnormal IRT concentrations were more frequent in patients of more than 12 years old, supranormal IRT concentrations were more frequent in younger patients. These data provide the first antemortem evidence of exocrine pancreatic damage in this condition. They also suggest that this acinar cell damage is initially associated with a rise in IRT which is followed by a fall in the serum concentration of this enzyme.

Full text

PDF
970

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dandona P., Elias E., Beckett A. G. Serum trypsin concentrations in diabetes mellitus. Br Med J. 1978 Oct 21;2(6145):1125–1125. doi: 10.1136/bmj.2.6145.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dandona P., Hodson M., Bell J., Ramdial L., Beldon I., Batten J. C. Serum immunoreactive trypsin in cystic fibrosis. Thorax. 1981 Jan;36(1):60–62. doi: 10.1136/thx.36.1.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elias E., Redshaw M., Wood T. Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet. 1977 Jul 9;2(8028):66–68. doi: 10.1016/s0140-6736(77)90066-6. [DOI] [PubMed] [Google Scholar]
  4. Hoffbrand A. V., Gorman A., Laulicht M., Garidi M., Economidou J., Georgipoulou P., Hussain M. A., Flynn D. M. Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet. 1979 May 5;1(8123):947–949. doi: 10.1016/s0140-6736(79)91721-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES